Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Jarecki

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Neuromuscular Diseases|November 11, 2019
Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA CohortCynthia C Jones, Suzanne F Cook, Jill Jarecki, et al.
Clinical Trials (London, England)|February 25, 2018
Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disordersHolly L Peay, Barbara B Biesecker, Benjamin S Wilfond, et al.
Prenatal Diagnosis|August 27, 2022
Investigating attitudes toward prenatal diagnosis and fetal therapy for spinal muscular atrophyMarisa E Schwab, Shirley Shao, Li Zhang, et al.
Journal of Neuromuscular Diseases|April 5, 2018
An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA membersLisa Belter, Suzanne F Cook, Thomas O Crawford, et al.
Assay and Drug Development Technologies|August 23, 2014
Assays for the identification and prioritization of drug candidates for spinal muscular atrophyJonathan J Cherry, Dione T Kobayashi, Maureen M Lynes, et al.
Journal of Neuromuscular Diseases|October 26, 2020
The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular AtrophyLisa Belter, Jill Jarecki, Sandra P Reyna, et al.
Journal of Neuromuscular Diseases|July 17, 2023
Identifying Biomarkers of Spinal Muscular Atrophy for Further DevelopmentJacqueline Glascock, Basil T Darras, Thomas O Crawford, et al.
Journal of Neuromuscular Diseases|April 5, 2018
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn ScreeningJacqueline Glascock, Jacinda Sampson, Amanda Haidet-Phillips, et al.
Annals of Neurology|November 5, 2003
Valproic acid increases SMN levels in spinal muscular atrophy patient cellsCharlotte J Sumner, Thanh N Huynh, Jennifer A Markowitz, et al.
Human Molecular Genetics|November 10, 2009
Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyMatthew E R Butchbach, Jasbir Singh, Margrét Thorsteinsdóttir, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Neuromuscular Diseases|November 11, 2019
Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA CohortCynthia C Jones, Suzanne F Cook, Jill Jarecki, et al.
Clinical Trials (London, England)|February 25, 2018
Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disordersHolly L Peay, Barbara B Biesecker, Benjamin S Wilfond, et al.
Prenatal Diagnosis|August 27, 2022
Investigating attitudes toward prenatal diagnosis and fetal therapy for spinal muscular atrophyMarisa E Schwab, Shirley Shao, Li Zhang, et al.
Journal of Neuromuscular Diseases|April 5, 2018
An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA membersLisa Belter, Suzanne F Cook, Thomas O Crawford, et al.
Assay and Drug Development Technologies|August 23, 2014
Assays for the identification and prioritization of drug candidates for spinal muscular atrophyJonathan J Cherry, Dione T Kobayashi, Maureen M Lynes, et al.
Journal of Neuromuscular Diseases|October 26, 2020
The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular AtrophyLisa Belter, Jill Jarecki, Sandra P Reyna, et al.
Journal of Neuromuscular Diseases|July 17, 2023
Identifying Biomarkers of Spinal Muscular Atrophy for Further DevelopmentJacqueline Glascock, Basil T Darras, Thomas O Crawford, et al.
Journal of Neuromuscular Diseases|April 5, 2018
Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn ScreeningJacqueline Glascock, Jacinda Sampson, Amanda Haidet-Phillips, et al.
Annals of Neurology|November 5, 2003
Valproic acid increases SMN levels in spinal muscular atrophy patient cellsCharlotte J Sumner, Thanh N Huynh, Jennifer A Markowitz, et al.
Human Molecular Genetics|November 10, 2009
Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyMatthew E R Butchbach, Jasbir Singh, Margrét Thorsteinsdóttir, et al.
Pageof 4